Cisplatin/epinephrine April 12, 2017 Cisplatin/epinephrine Trade Name Intradose Orphan Indication Metastatic malignant melanoma USA Market Approval USA USA Designation Date 2000-09-07 00:00:00 Sponsor Matrix Pharmaceutical, Inc.;34700 Campus Drive;Fremont, California, 94555
